Rekah Pharmaceutical Industry Ltd. (TLV: REKA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,349.00
-51.00 (-3.64%)
Dec 19, 2024, 5:24 PM IDT

TLV: REKA Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
154169176266306228
Upgrade
Market Cap Growth
-19.34%-3.96%-33.89%-13.13%34.20%-22.45%
Upgrade
Enterprise Value
298338321420441334
Upgrade
Last Close Price
13.4814.7815.3922.4025.7919.21
Upgrade
PE Ratio
19.97--40.1228.3357.17
Upgrade
PS Ratio
0.460.520.601.011.151.16
Upgrade
PB Ratio
0.941.081.081.541.851.47
Upgrade
P/TBV Ratio
1.601.901.391.901.901.49
Upgrade
P/FCF Ratio
11.6210.015.4834.59--
Upgrade
P/OCF Ratio
6.945.954.5012.5527.116.72
Upgrade
EV/Sales Ratio
0.901.051.101.591.661.70
Upgrade
EV/EBITDA Ratio
6.1113.009.2711.7310.8611.32
Upgrade
EV/EBIT Ratio
18.41116.4324.2032.4921.1026.50
Upgrade
EV/FCF Ratio
22.4720.0710.0054.61--
Upgrade
Debt / Equity Ratio
0.901.191.020.961.000.93
Upgrade
Debt / EBITDA Ratio
3.035.674.074.644.104.89
Upgrade
Debt / FCF Ratio
11.1311.025.1721.59--
Upgrade
Asset Turnover
0.720.690.660.620.670.59
Upgrade
Inventory Turnover
2.902.562.352.122.361.76
Upgrade
Quick Ratio
0.891.011.061.301.171.25
Upgrade
Current Ratio
1.431.751.752.252.102.10
Upgrade
Return on Equity (ROE)
4.75%-4.35%-1.22%3.91%6.73%1.80%
Upgrade
Return on Assets (ROA)
2.18%0.39%1.87%1.88%3.32%2.36%
Upgrade
Return on Capital (ROIC)
3.09%0.54%2.48%2.41%4.14%2.95%
Upgrade
Earnings Yield
4.66%-4.10%-1.16%2.49%3.53%1.75%
Upgrade
FCF Yield
8.09%9.99%18.25%2.89%-2.40%-4.04%
Upgrade
Dividend Yield
0.00%--3.87%--
Upgrade
Buyback Yield / Dilution
-9.50%-----1.03%
Upgrade
Total Shareholder Return
-9.50%--3.87%--1.03%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.